Drug Approval | July 19, 2024
Kwality Pharmaceuticals receives DIGIMED approval for generic, injectable and OSD
Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration
Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
Exblifeb demonstrates remarkable efficacy in treating complicated Urinary Tract Infections (cUTI), pneumonia
Subscribe To Our Newsletter & Stay Updated
